FDA Approves New Lung Cancer Immunotherapy | Newark News

FDA just approved a groundbreaking immunotherapy for advanced non-small cell lung cancer, offering new hope to patients who’ve already tried other treatments. This drug, which blocks a protein cancer uses to hide from the immune system, helps the body’s own defenses attack tumors more effectively. Clinical trials showed it shrinks tumors and delays progression better than standard chemo, with manageable side effects. It’s a major leap in personalized cancer care, proving that science is turning the tide against some of medicine’s toughest challenges. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/fe21b0289ed44646